TRELLUS HEALTH LS -0006
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated… Read more
TRELLUS HEALTH LS -0006 (85Q) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, TRELLUS HEALTH LS -0006 (85Q) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
TRELLUS HEALTH LS -0006 - Net Assets Trend (None–None)
This chart illustrates how TRELLUS HEALTH LS -0006's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for TRELLUS HEALTH LS -0006 (None–None)
The table below shows the annual net assets of TRELLUS HEALTH LS -0006 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to TRELLUS HEALTH LS -0006's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
TRELLUS HEALTH LS -0006 Competitors by Market Cap
The table below lists competitors of TRELLUS HEALTH LS -0006 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
COGENT COMM GRP
BE:OGM1
|
$186.28K |
|
CAMPBELL SOUP - Dusseldorf Stock Exchang
DU:CSC
|
$186.72K |
|
CAPTOR THHERAP. ZY-10
F:60Q
|
$186.72K |
|
XBS Pro Log SA
WAR:XBS
|
$186.74K |
|
Aegon Funding Company LLC 5.10%
NYSE:AEFC
|
$186.15K |
|
ANY SECURITY
BE:X07
|
$186.13K |
|
SAREPTA THERAP
BE:AB3A
|
$186.07K |
|
CHRB
PINK:CHRB
|
$185.95K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in TRELLUS HEALTH LS -0006's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares TRELLUS HEALTH LS -0006's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently TRELLUS HEALTH LS -0006 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares TRELLUS HEALTH LS -0006's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,807,324,866
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| TRELLUS HEALTH LS -0006 (85Q) | €- | N/A | N/A | $186.19K |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $631.00 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $371.65K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.71 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.75 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.89 Million |